Akiko Yoshida

Mrs. Akiko Yoshida

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2023 in Genes
Verified
Journal Article
Open access
PDF file
AYAkiko Yoshida
Akiko Yoshida
Tomoharu TokutomiTomoharu Tokutomi
Tomoharu Tokutomi
AFAkimune Fukushima
Akimune Fukushima
RCRobert Chapman
Robert Chapman
Fatos SelitaFatos Selita
Fatos Selita
MSMakoto Sasaki
Makoto Sasaki
Knowledge of genetics is essential for understanding the results of genetic testing and its implications. Recent advances in genomic research have allowed us to predict the risk of onset of common diseases based on individual genomic information. It is anticipated that more people will receive such estimates of risks based on their genomic data. However, currently, there is no measure for genetic knowledge that includes post-genome sequencing advancements in Japan. In this study, we translated the genomic knowledge measure in the International Genetics Literacy and Attitudes Survey (iGLAS-GK) into Japanese and validated it in a general Japanese adult population (n = 463). The mean score was 8.41 (SD 2.56, range 3–17). The skewness and kurtosis were 0.534 and 0.088, respectively, and the distribution showed a slightly positive skewness. Exploratory factor analysis proposed a six-factor model. Results for 16 of the 20 items of the Japanese version of the iGLAS-GK were comparable to those from previous studies in other populations. These results indicate that the Japanese version is reliable and can be used to measure the genomic knowledge of adults in the general population, and this version of the knowledge measure maintains the multidimensional structure for assessing genomic knowledge.

18 April 2023 in Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
TSTomohiro Sakaguchi
Tomohiro Sakaguchi
Tomoharu TokutomiTomoharu Tokutomi
Tomoharu Tokutomi
AYAkiko Yoshida
Akiko Yoshida
KYKayono Yamamoto
Kayono Yamamoto
KOKeiko Obata
Keiko Obata
AFAkimune Fukushima
Akimune Fukushima

21 March 2024 in Genes
Verified
Journal Article
Open access
PDF file
Tomoharu TokutomiTomoharu Tokutomi
Tomoharu Tokutomi
AYAkiko Yoshida
Akiko Yoshida
AFAkimune Fukushima
Akimune Fukushima
KYKayono Yamamoto
Kayono Yamamoto
IYISHIGAKI YASUSHI
ISHIGAKI YASUSHI
MSMakoto Sasaki
Makoto Sasaki
Genetic testing is key in modern healthcare, particularly for monogenic disorders such as familial hypercholesterolemia. This Tohoku Medical Megabank Project study explored the impact of first-degree relatives’ dyslipidemia history on individual responses to familial hypercholesterolemia genomic results. Involving 214 participants and using Japan’s 3.5KJPN genome reference panel, the study assessed preferences and intentions regarding familial hypercholesterolemia genetic testing results. The data revealed a significant inclination among participants with a family history of dyslipidemia to share their genetic test results, with more than 80% of participants intending to share positive results with their partners and children and 98.1% acknowledging the usefulness of positive results for personal health management. The study underscores the importance of family health history in genetic-testing perceptions, highlighting the need for family-centered approaches in genetic counseling and healthcare. Notable study limitations include the regional scope and reliance on questionnaire data. The study results emphasize the association between family health history and genetic-testing attitudes and decisions.

28 December 2023 in Genes
Verified
Journal Article
Open access
PDF file
Tomoharu TokutomiTomoharu Tokutomi
Tomoharu Tokutomi
AYAkiko Yoshida
Akiko Yoshida
AFAkimune Fukushima
Akimune Fukushima
FNFuji Nagami
Fuji Nagami
YMYuko Minoura
Yuko Minoura
MSMakoto Sasaki
Makoto Sasaki
Genome-wide association studies have been employed to develop numerous risk prediction models using polygenic risk scores (PRSs) for multifactorial diseases. However, healthcare providers lack confidence in their understanding of PRS risk stratification for multifactorial diseases, which underscores the need to assess the readiness of PRSs for clinical use. To address this issue, we surveyed the perceptions of healthcare providers as stakeholders in the clinical implementation of genetic-based risk prediction for multifactorial diseases. We conducted a web-based study on the need for risk prediction based on genetic information and the appropriate timing of testing for 12 multifactorial diseases. Responses were obtained from 506 stakeholders. Positive perceptions of genetic risk testing were found for adult-onset chronic diseases. As per participant opinion, testing for adult-onset diseases should be performed after the age of 20 years, whereas testing for psychiatric and allergic disorders that manifest during childhood should be performed from birth to 19 years of age. The stakeholders recognized the need for genetic risk testing for diseases that develop in adulthood, believing that the appropriate testing time is after maturity. This study contributes to the discussion on the clinical implementation of the PRS for genetic risk prediction of multifactorial diseases.

6 September 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
Tomoharu TokutomiTomoharu Tokutomi
Tomoharu Tokutomi
AYAkiko Yoshida
Akiko Yoshida
KMKunihiko Miura
Kunihiko Miura
Background: Family health history (FHH) is essential for genomic medicine and risk assessment, but its completeness in Japanese prenatal settings is poorly understood. Prior studies show that details such as cause of death (COD) and age at onset are often missing. To address this gap, we conducted a pilot observational exploratory study evaluating FHH completeness in a Japanese prenatal genetic counseling setting. Methods: We analyzed data from 24 participants (12 couples) who underwent prenatal genetic counseling at a university hospital, most of whom were of advanced maternal age and had undergone non-invasive prenatal testing (NIPT). FHH was collected using a structured form at the first visit and revised at the second visit. Completeness was assessed for four items: medical history, age at death, COD, and age at disease onset. Associations with participant characteristics were also explored. Results: Disease history was most complete, while COD and age at onset were frequently missing. Age at death was more complete than COD, indicating that information on deceased relatives or timelines was harder to obtain. Participants with personal or family medical conditions tended to provide more complete FHH. The structured form and opportunity for revision likely enhanced completeness. Conclusions: This pilot study shows that COD and age at onset are the least complete components of FHH in Japanese prenatal counseling. The small sample size and single-hospital setting limit the generalizability of the findings, but they suggest that structured prompts and preparation before visits may improve FHH completeness and enhance risk assessment in clinical practice.

5 February 2026 in Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
AYAkiko Yoshida
Akiko Yoshida
Tomoharu TokutomiTomoharu Tokutomi
Tomoharu Tokutomi
NSNobuhiro Suzumori
Nobuhiro Suzumori
AFAkimune Fukushima
Akimune Fukushima
YTYukiko Toya
Yukiko Toya
MSMakoto Sasaki
Makoto Sasaki
Background: The potential impacts of polygenic scores (PGS) on health-behavior changes are not fully understood. The Iwate PGS Assessment and Risk Communication Study aims to investigate the effects of reporting PGS-based risk for ischemic stroke on health behaviors.Methods: Participants wishing to know their PGS-based ischemic stroke risk were recruited from health checkup venues for workers in Iwate Prefecture in 2023. Health checkup data, biospecimens, and questionnaire responses were collected for biochemical testing, genotyping, and storage in the Tohoku Medical Megabank integrated biobank. The risk was calculated using an integrative PGS model for East Asians. Participants were randomly assigned to two groups, and one group received their risk report as the intervention group. The impacts of the risk notification will be investigated in follow-up surveys.Results: Of 3,599 workers, 2,088 participated in the study (consent rate, 58.0%). The demographic profile of the eligible 2,083 participants was as follows: 80.7% males, and dominance of participants aged 18–29 years (25.2%), in their 30's (25.3%), and in their 40's (24.7%). Two hundred participants (9.7%) had a risk of 1.0 as the reference; 57 (2.7%), 927 (44.7%), and 888 (42.9%) participants had 2.1–3.4-, 1.4–1.9-, and <1.0-fold that risk, respectively.Conclusion: We collected health information and biospecimens from over 2,000 workers, and disclosed the PGS-based ischemic stroke risk. Behavioral effects will be evaluated 1 year after disclosure, with follow-up until 2030. As Japan's first large-scale PGS risk communication study, it will provide initial insights for implementing PGS in personalized preventive medicine.